Full Text View
Tabular View
No Study Results Posted
Related Studies
Pharmacokinetics and Safety of Moxifloxacin (MFX468)
This study is currently recruiting participants.
Verified October 2012 by University Medical Centre Groningen
Study NCT01329250   Information provided by University Medical Centre Groningen

First Received on March 8, 2011.   Last Updated on October 22, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Tuberculosis
More general conditions related to this trial
Actinomycetales Infections
Bacterial Infections
Gram-Positive Bacterial Infections
Mycobacterium Infections
Interventions listed in this trial
Moxifloxacin
Additional drug interventions recognized in this trial
Norgestimate, ethinyl estradiol drug combination
More general drug interventions related to this trial
Anti-Infective Agents
Contraceptive Agents
Contraceptive Agents, Female
Contraceptives, Oral
Contraceptives, Oral, Combined
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
University Medical Centre Groningen


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services